NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, April 17, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

https://static.prnasia.com/pro/fec/jwplayer-7.12.1/jwplayer.js jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”

 

NYSE_Market_Update_April_17 jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2959306/NYSE_Market_Update_April_17.mp4’, image: ‘https://mma.prnasia.com/media2/2959306/NYSE_Market_Update_April_17.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Ashley Mastronardi delivers the pre-market update on April 17th

  • Markets are up Friday morning after President Trump said late Thursday that the conflict in Iran "should be ending pretty soon."
  • Aevex (NYSE: AVEX) CEO Roger Wells will join NYSE Live this morning to discuss its strategy as the firm prepares to begin trading on the NYSE.
  • Shares of Madison Air (NYSE: MAIR) popped by more than 17% in its first day of trading on the NYSE Thursday.
  • Parker Institute of Cancer Immunotherapy CEO Karen Knudsen will join NYSE Live to elaborate on its collaboration with the Cancer Vaccine Coalition.

Opening Bell
Aevex (NYSE: AVEX) celebrates its IPO and NYSE debut

Closing Bell
Pinnacle West Capital (NYSE: PNW) marks its 65th anniversary of listing

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

NYSE_Morgan_Stanley
NYSE_Morgan_Stanley

 

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Shield AI V-BAT Selected as Japan Maritime Self-Defense Force's First Maritime ISR Platform

WASHINGTON, Jan. 22, 2025 /PRNewswire/ — Shield AI, the defense technology company…

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy

NANTONG, China, Dec. 12, 2025 /PRNewswire/ — Ractigen Therapeutics, a pioneering developer of…

MCO (MyComplianceOffice) Rises to #42 in the Chartis RiskTech100 2026

NEW YORK, Oct. 23, 2025 /PRNewswire/ — MCO (MyComplianceOffice) has advanced to #42…